Loading...
XKRX
096530
Market cap1.30bUSD
Oct 08, Last price  
38,150.00KRW
1D
-1.93%
1Q
31.55%
Jan 2017
9.16%
IPO
-1.84%
Name

Seegene Inc

Chart & performance

D1W1MN
XKRX:096530 chart
P/E
35.88
P/S
3.67
EPS
1,063.22
Div yield, %
2.54%
Shrs. gr., 5y
0.09%
Rev. gr., 5y
-15.87%
Revenues
474.23b
+14.48%
51,712,796,63058,992,832,19064,410,877,29065,136,597,35773,693,589,45888,919,576,022102,264,773,396121,953,286,8751,125,215,548,0001,370,833,012,000853,561,091,000367,375,049,000414,251,733,000474,232,000,000
Net income
48.45b
P
9,102,938,4159,572,517,8609,141,388,0906,774,128,6017,122,595,5823,186,975,04510,098,321,71226,672,069,051502,281,109,000536,558,868,000182,138,621,000669,012,000-20,336,849,00048,445,000,000
CFO
149.33b
+74.88%
3,672,940,358-2,893,225,7806,777,155,7004,104,835,65416,557,316,93710,115,432,38814,009,661,69532,643,052,000383,157,254,000334,024,477,000319,008,874,00094,932,061,00085,390,805,000149,333,824,000
Dividend
Sep 29, 2026200 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of SNPs in factor II, factor V, and MTHFR genes. The company has a collaboration with Werfen for the joint development of syndromic qPCR assays. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.

Key people

Jong Yun Cheon
Co-Chief Executive Officer, Director · since 2024
Beom Jun Kim
Vice President · since 2023
Jun Beom Kim
Vice President · since 2024
Gi Seon Lee
Vice President · since 2020
Sang Heon Shin
Vice President · since 2022
Dae Ho Shin
Vice President · since 2023
Bu Hyeon Yang
Vice President · since 2021
Dae Hyeok Ahn
Managing Director · since 2022
Eun Sin Bae
Managing Director · since 2024
Eun Cheol Cho
Managing Director · since 2021
Dae Yeop Choi
Managing Director · since 2018
Yin Taek Hwang
Managing Director · since 2021
Seung Gu Kang
Managing Director · since 2020
Do Yeon Kim
Managing Director · since 2020
Jin Ho Kim
Managing Director · since 2017
Jeong Yong Kim
Managing Director · since 2023
Seong Yeol Kim
Managing Director · since 2021
Yong Rae Lee
Managing Director · since 2021
Si Won Noh
Managing Director · since 2023
Dong Ju Seo
Managing Director · since 2022
IPO date
Sep 10, 2010
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT